Veradermics
MANE | NYSE
$133.43
-$6.26 (-4.48%)
Nov 2, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
PE Ratio | -15.86 | -269.64 | -460.93 |
PEG Ratio | -0.01 | -3.80 | n/a |
PS Ratio | n/a | n/a | n/a |
PB Ratio | -10.94 | 139.04 | 519.93 |
P/FCF Ratio | -18.49 | -320.85 | -562.57 |
P/OCF Ratio | -18.49 | -320.85 | -562.57 |
OCF/S Ratio | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | n/a | 0.05 |
Quick Ratio | 16.66 | 11.77 | 5.75 |
Current Ratio | 16.66 | 11.77 | 5.75 |
Asset Turnover | n/a | n/a | n/a |
Interest Coverage | n/a | -45.77 | -481.22 |
Return on Equity | 57.84% | -48.46% | -112.81% |
Return on Assets | -45.86% | -44.61% | -89.35% |
Return on Invested Capital | -50.43% | -48.99% | -112.46% |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MANE